<p>In the first segment, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis. In the second part of the podcast, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer’s disease diagnosis and experience participating in a clinical trial for aducanumab.</p>

In the first segment, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis. In the second part of the podcast, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer’s disease diagnosis and experience participating in a clinical trial for aducanumab.

Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Share Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's

Sign up to save your podcasts

Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's

Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's

More shows like Neurology® Podcast

JAMA Editors' Summary

NEJM This Week

Practical Neurology Podcast

JAMA Clinical Reviews

The Curbsiders Internal Medicine Podcast

JAMA Neurology Author Interviews

Core IM | Internal Medicine Podcast

Neurology Today in 5

Annals On Call Podcast

The Clinical Problem Solvers

Neurology Minute

Harrison's PodClass: Internal Medicine Cases and Board Prep

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio